Clinical Drug Experience Knowledgebase

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

covax (2 trials)

covax-19 (2 trials)

covid-19 vaccine (vero cells) (3 trials)

dtap (5 trials)

hepatitis a vaccine, inactivated (vaqta) (1 trial)

inactivated covid-19 vaccine (4 trials)

inactivated influenza vaccine (1 trial)

ipv (3 trials)

live oral poliovirus type 1, 2 and 3 (2 trials)

measles, mumps and rubella vaccine (1 trial)

mmr (1 trial)

sipv (1 trial)

bivalent oral polio vaccine (bopv), type 1 and type 3 (2 trials)

haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

inactivated SARS-Cov-2 vaccine (2 trials)

tdap-ipv vaccine (1 trial)

nvsi-06-08 (1 trial)